Peri-Implantitis Treatment Market Segmentation by Type {Surgical (Bone Regeneration, Open Flap Debridement, and Implantoplasty), and Non-surgical (Mechanical Debridement, Laser Debridement, Antibiotics, and Others)}; and by End-User (Dental Clinics, Hospitals, Pharmacies, and Others) – Global Demand Analysis & Opportunity Outlook 2031

Global Peri-Implantitis Treatment Market Highlights over 2022 – 2031

The global peri-implantitis treatment market is estimated to grow at a CAGR of ~8% over the forecast period, i.e., 2022 – 2031. Peri-implantitis is a site-specific infectious disease that causes inflammations in the hard and soft tissue surrounding a dental implant. Various factors, such as, poor design of the dental implants, excessive mechanical stress, and corrosion of metal may cause peri-implantitis. The growth of the market can be attributed to the growing demand for dental implants, along with the adoption of advanced technology in the oral healthcare sector. The growing prevalence of oral diseases is also estimated to encourage the market growth. According the data by the World Health Organization (WHO), nearly 3.5 billion people are affected by oral diseases across the globe. Moreover, almost 10% of the global population is affected with severe periodontal (gum) disease, which may result in tooth loss. Such factors are estimated to boost the market growth.

The market is bifurcated by type into surgical and non-surgical, out of which the surgical segment is further sub segmented into bone regeneration, open flap debridement, and implantoplasty. On the other hand, the non-surgical segment is also sub segmented into mechanical debridement, laser debridement, antibiotics, and others. Among these, the surgical segment is estimated to hold the largest share in the global peri-implantitis treatment market over the forecast period as surgeries offer immediate relief and higher success rate of permanent cure. Moreover, surgery is a quicker treatment process, whereas antibiotics and other non-surgical methods take a significant amount of time. This is why, people prefer surgical treatment, which is estimate to boost the segment growth. CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Peri-Implantitis Treatment Market Regional Synopsis

On the basis of geographical analysis, the global peri-implantitis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of increasing prevalence of oral diseases, along with rising awareness regarding oral health.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the growing incidences of oral diseases. As per the data by the Center for Disease Control and Prevention (CDC), 46% of all adults, aged 30 years or older, suffer from some kind of gum disease while 9% of adults are affected by severe gum diseases.

The global peri-implantitis treatment market is further classified on the basis of region as follows:

• North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

• Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global peri-implantitis treatment market includes the following segments:

By Type

• Surgical
  • Bone Regeneration
  • Open Flap Debridement
  • Implantoplasty
• Non-Surgical
  • Mechanical Debridement
  • Laser Debridement
  • Antibiotics
  • Others

By End-User

• Dental Clinics
• Hospitals
• Pharmacies
• Others

Growth Drivers

• Increasing Need for Dental Implants backed by Poor Oral Health
• Growing Awareness amongst People Regarding Oral Health

Challenges

• Difficult Diagnosis of Peri-implantitis
• Lack of Awareness regarding the Disease

Top Featured Companies Dominating the Market

• Aetna Inc.
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 
• Pfizer Inc.
• Cadila Pharmaceuticals
• R.N. Laboratories Pvt. Ltd.
• Neoss Limited
• Basic Pharma Life Science Pvt. Ltd.
• Dawood and Tanner
• Prachi Pharmaceuticals Private Limited
• Geistlich Pharma Inc.
• Healthy Life Pharma Pvt. Ltd.